HEADER HYDROLASE 03-DEC-98 1B2Y
TITLE STRUCTURE OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH THE
TITLE 2 CARBOHYDRATE INHIBITOR ACARBOSE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PANCREATIC ALPHA-AMYLASE;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: PA,1,4-ALPHA-D-GLUCAN GLUCANOHYDROLASE;
COMPND 5 EC: 3.2.1.1
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 ORGAN: PANCREAS
KEYWDS HUMAN ALPHA-AMYLASE, ACARBOSE, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR V.NAHOUM,F.PAYAN
REVDAT 9 06-NOV-24 1B2Y 1 REMARK
REVDAT 8 20-SEP-23 1B2Y 1 REMARK
REVDAT 7 22-FEB-23 1B2Y 1 COMPND SOURCE REMARK DBREF
REVDAT 7 2 1 SEQRES HETSYN LINK ATOM
REVDAT 6 29-JUL-20 1B2Y 1 COMPND REMARK HETNAM LINK
REVDAT 6 2 1 SITE ATOM
REVDAT 5 25-OCT-17 1B2Y 1 HETSYN ATOM
REVDAT 4 25-AUG-09 1B2Y 1 HET
REVDAT 3 24-FEB-09 1B2Y 1 VERSN
REVDAT 2 01-APR-03 1B2Y 1 JRNL
REVDAT 1 16-FEB-00 1B2Y 0
JRNL AUTH V.NAHOUM,G.ROUX,V.ANTON,P.ROUGE,A.PUIGSERVER,H.BISCHOFF,
JRNL AUTH 2 B.HENRISSAT,F.PAYAN
JRNL TITL CRYSTAL STRUCTURES OF HUMAN PANCREATIC ALPHA-AMYLASE IN
JRNL TITL 2 COMPLEX WITH CARBOHYDRATE AND PROTEINACEOUS INHIBITORS.
JRNL REF BIOCHEM.J. V.PT 1 201 2000
JRNL REFN ISSN 0264-6021
JRNL PMID 10657258
JRNL DOI 10.1042/0264-6021:3460201
REMARK 2
REMARK 2 RESOLUTION. 3.20 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR 3.843
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 11.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1000000.000
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.5
REMARK 3 NUMBER OF REFLECTIONS : 8957
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.191
REMARK 3 FREE R VALUE : 0.217
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.000
REMARK 3 FREE R VALUE TEST SET COUNT : 826
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 8
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.34
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.70
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 932
REMARK 3 BIN R VALUE (WORKING SET) : 0.2150
REMARK 3 BIN FREE R VALUE : 0.2830
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.00
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 77
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3946
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 56
REMARK 3 SOLVENT ATOMS : 105
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 30.00
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 9.50
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : 11.0
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.015
REMARK 3 BOND ANGLES (DEGREES) : 1.900
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 2.100 ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.200 ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : 3.000 ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.900 ; NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1B2Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JUL-99.
REMARK 100 THE DEPOSITION ID IS D_1000007334.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 15-JUL-98
REMARK 200 TEMPERATURE (KELVIN) : 293
REMARK 200 PH : 8.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : NULL
REMARK 200 DETECTOR MANUFACTURER : NULL
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10103
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200
REMARK 200 RESOLUTION RANGE LOW (A) : 25.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 91.8
REMARK 200 DATA REDUNDANCY : 4.400
REMARK 200 R MERGE (I) : 0.15800
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.27
REMARK 200 COMPLETENESS FOR SHELL (%) : 63.4
REMARK 200 DATA REDUNDANCY IN SHELL : 9.00
REMARK 200 R MERGE FOR SHELL (I) : 0.28600
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.700
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: PDB ENTRY 1HNY
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 60.00
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 60% 2-METHYLPENTAN-2,4 DIOL, PH 8.0
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.55500
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.56500
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.55000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 68.56500
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.55500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.55000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 CYS A 70 CA - CB - SG ANGL. DEV. = 7.7 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 TYR A 31 -54.58 -140.79
REMARK 500 MET A 102 -146.49 -113.67
REMARK 500 PHE A 126 77.21 -118.18
REMARK 500 LEU A 166 105.12 -57.92
REMARK 500 ASN A 270 27.14 48.15
REMARK 500 ASP A 317 57.41 -104.49
REMARK 500 SER A 414 -109.99 -126.78
REMARK 500 SER A 437 100.11 -161.77
REMARK 500 ASN A 459 69.99 39.49
REMARK 500 PRO A 486 43.84 -77.97
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 PYRROLIDONE CARBOXYLIC-ACID
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 CA A2502 CA
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASN A 100 OD1
REMARK 620 2 ARG A 158 O 157.5
REMARK 620 3 ASP A 167 OD1 79.1 112.8
REMARK 620 4 ASP A 167 OD2 125.1 74.3 50.4
REMARK 620 5 HIS A 201 O 78.5 79.5 131.1 149.1
REMARK 620 6 HOH A2606 O 71.3 129.4 73.7 74.5 136.0
REMARK 620 7 HOH A2607 O 95.4 75.8 61.0 79.4 78.6 134.5
REMARK 620 8 HOH A2665 O 113.0 76.5 125.7 86.4 103.1 62.7 151.4
REMARK 620 N 1 2 3 4 5 6 7
REMARK 650
REMARK 650 HELIX
REMARK 650 DETERMINATION METHOD: AUTHOR-DETERMINED
REMARK 700
REMARK 700 SHEET
REMARK 700 DETERMINATION METHOD: AUTHOR-DETERMINED
DBREF 1B2Y A 1 496 UNP P04746 AMYP_HUMAN 16 511
SEQRES 1 A 496 PCA TYR SER PRO ASN THR GLN GLN GLY ARG THR SER ILE
SEQRES 2 A 496 VAL HIS LEU PHE GLU TRP ARG TRP VAL ASP ILE ALA LEU
SEQRES 3 A 496 GLU CYS GLU ARG TYR LEU ALA PRO LYS GLY PHE GLY GLY
SEQRES 4 A 496 VAL GLN VAL SER PRO PRO ASN GLU ASN VAL ALA ILE TYR
SEQRES 5 A 496 ASN PRO PHE ARG PRO TRP TRP GLU ARG TYR GLN PRO VAL
SEQRES 6 A 496 SER TYR LYS LEU CYS THR ARG SER GLY ASN GLU ASP GLU
SEQRES 7 A 496 PHE ARG ASN MET VAL THR ARG CYS ASN ASN VAL GLY VAL
SEQRES 8 A 496 ARG ILE TYR VAL ASP ALA VAL ILE ASN HIS MET CYS GLY
SEQRES 9 A 496 ASN ALA VAL SER ALA GLY THR SER SER THR CYS GLY SER
SEQRES 10 A 496 TYR PHE ASN PRO GLY SER ARG ASP PHE PRO ALA VAL PRO
SEQRES 11 A 496 TYR SER GLY TRP ASP PHE ASN ASP GLY LYS CYS LYS THR
SEQRES 12 A 496 GLY SER GLY ASP ILE GLU ASN TYR ASN ASP ALA THR GLN
SEQRES 13 A 496 VAL ARG ASP CYS ARG LEU THR GLY LEU LEU ASP LEU ALA
SEQRES 14 A 496 LEU GLU LYS ASP TYR VAL ARG SER LYS ILE ALA GLU TYR
SEQRES 15 A 496 MET ASN HIS LEU ILE ASP ILE GLY VAL ALA GLY PHE ARG
SEQRES 16 A 496 LEU ASP ALA SER LYS HIS MET TRP PRO GLY ASP ILE LYS
SEQRES 17 A 496 ALA ILE LEU ASP LYS LEU HIS ASN LEU ASN SER ASN TRP
SEQRES 18 A 496 PHE PRO ALA GLY SER LYS PRO PHE ILE TYR GLN GLU VAL
SEQRES 19 A 496 ILE ASP LEU GLY GLY GLU PRO ILE LYS SER SER ASP TYR
SEQRES 20 A 496 PHE GLY ASN GLY ARG VAL THR GLU PHE LYS TYR GLY ALA
SEQRES 21 A 496 LYS LEU GLY THR VAL ILE ARG LYS TRP ASN GLY GLU LYS
SEQRES 22 A 496 MET SER TYR LEU LYS ASN TRP GLY GLU GLY TRP GLY PHE
SEQRES 23 A 496 VAL PRO SER ASP ARG ALA LEU VAL PHE VAL ASP ASN HIS
SEQRES 24 A 496 ASP ASN GLN ARG GLY HIS GLY ALA GLY GLY ALA SER ILE
SEQRES 25 A 496 LEU THR PHE TRP ASP ALA ARG LEU TYR LYS MET ALA VAL
SEQRES 26 A 496 GLY PHE MET LEU ALA HIS PRO TYR GLY PHE THR ARG VAL
SEQRES 27 A 496 MET SER SER TYR ARG TRP PRO ARG GLN PHE GLN ASN GLY
SEQRES 28 A 496 ASN ASP VAL ASN ASP TRP VAL GLY PRO PRO ASN ASN ASN
SEQRES 29 A 496 GLY VAL ILE LYS GLU VAL THR ILE ASN PRO ASP THR THR
SEQRES 30 A 496 CYS GLY ASN ASP TRP VAL CYS GLU HIS ARG TRP ARG GLN
SEQRES 31 A 496 ILE ARG ASN MET VAL ILE PHE ARG ASN VAL VAL ASP GLY
SEQRES 32 A 496 GLN PRO PHE THR ASN TRP TYR ASP ASN GLY SER ASN GLN
SEQRES 33 A 496 VAL ALA PHE GLY ARG GLY ASN ARG GLY PHE ILE VAL PHE
SEQRES 34 A 496 ASN ASN ASP ASP TRP SER PHE SER LEU THR LEU GLN THR
SEQRES 35 A 496 GLY LEU PRO ALA GLY THR TYR CYS ASP VAL ILE SER GLY
SEQRES 36 A 496 ASP LYS ILE ASN GLY ASN CYS THR GLY ILE LYS ILE TYR
SEQRES 37 A 496 VAL SER ASP ASP GLY LYS ALA HIS PHE SER ILE SER ASN
SEQRES 38 A 496 SER ALA GLU ASP PRO PHE ILE ALA ILE HIS ALA GLU SER
SEQRES 39 A 496 LYS LEU
MODRES 1B2Y PCA A 1 GLN MODIFIED RESIDUE
HET PCA A 1 8
HET BGC B 1 12
HET AC1 B 2 21
HET GLC B 3 11
HET G6D B 4 10
HET CL A2501 1
HET CA A2502 1
HETNAM PCA PYROGLUTAMIC ACID
HETNAM BGC BETA-D-GLUCOPYRANOSE
HETNAM AC1 4,6-DIDEOXY-4-{[(1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-
HETNAM 2 AC1 (HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}-ALPHA-D-
HETNAM 3 AC1 GLUCOPYRANOSE
HETNAM GLC ALPHA-D-GLUCOPYRANOSE
HETNAM G6D ALPHA-D-QUINOVOPYRANOSE
HETNAM CL CHLORIDE ION
HETNAM CA CALCIUM ION
HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE
HETSYN AC1 6-METHYL-5-(4,5,6-TRIHYDROXY-3-HYDROXYMETHYL-CYCLOHEX-
HETSYN 2 AC1 2-ENYLAMINO)-TETRAHYDRO-PYRAN-2,3,4-TRIOL; 4,6-
HETSYN 3 AC1 DIDEOXY-4-{[(1S,4R,5S,6S)-4,5,6-TRIHYDROXY-3-
HETSYN 4 AC1 (HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}-ALPHA-D-
HETSYN 5 AC1 GLUCOSE; 4,6-DIDEOXY-4-{[(1S,4R,5S,6S)-4,5,6-
HETSYN 6 AC1 TRIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}-
HETSYN 7 AC1 D-GLUCOSE; 4,6-DIDEOXY-4-{[(1S,4R,5S,6S)-4,5,6-
HETSYN 8 AC1 TRIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}-
HETSYN 9 AC1 GLUCOSE
HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE
HETSYN G6D ALPHA-D-QUINOVOSE; 6-DEOXY-ALPHA-D-GLUCOPYRANOSE; D-
HETSYN 2 G6D QUINOVOSE; QUINOVOSE; 6-DEOXY-ALPHA-D-GLUCOSE
FORMUL 1 PCA C5 H7 N O3
FORMUL 2 BGC C6 H12 O6
FORMUL 2 AC1 C13 H23 N O8
FORMUL 2 GLC C6 H12 O6
FORMUL 2 G6D C6 H12 O5
FORMUL 3 CL CL 1-
FORMUL 4 CA CA 2+
FORMUL 5 HOH *105(H2 O)
HELIX 1 H1 TRP A 21 ARG A 30 1 10
HELIX 2 H2 GLU A 76 VAL A 89 1 14
HELIX 3 H3 ASP A 173 ILE A 189 1 17
HELIX 4 H4 PRO A 204 LYS A 213 1 10
HELIX 5 H5 SER A 244 TYR A 247 5 4
HELIX 6 H6 PHE A 256 ARG A 267 1 12
HELIX 7 H7 MET A 274 ASN A 279 5 6
HELIX 8 H8 PHE A 315 ALA A 330 5 16
HELIX 9 H9 ARG A 389 VAL A 401 1 13
SHEET 1 S1 1 THR A 336 SER A 340 0
SHEET 1 S2 1 SER A 12 LEU A 16 0
SHEET 1 S3 1 GLY A 39 VAL A 42 0
SHEET 1 S4 1 ARG A 92 ALA A 97 0
SHEET 1 S5 1 GLY A 193 LEU A 196 0
SHEET 1 S6 1 PHE A 229 GLN A 232 0
SHEET 1 S7 1 GLN A 416 ARG A 421 0
SHEET 1 S8 1 GLY A 425 ASN A 430 0
SHEET 1 S9 1 PHE A 487 HIS A 491 0
SHEET 1 S10 1 PHE A 436 GLN A 441 0
SHEET 1 S11 1 LYS A 474 ILE A 479 0
SHEET 1 S12 1 GLY A 447 CYS A 450 0
SHEET 1 S13 1 LYS A 466 VAL A 469 0
SSBOND 1 CYS A 28 CYS A 86 1555 1555 2.04
SSBOND 2 CYS A 70 CYS A 115 1555 1555 2.04
SSBOND 3 CYS A 141 CYS A 160 1555 1555 2.02
SSBOND 4 CYS A 378 CYS A 384 1555 1555 2.03
SSBOND 5 CYS A 450 CYS A 462 1555 1555 2.02
LINK C PCA A 1 N TYR A 2 1555 1555 1.33
LINK O4 BGC B 1 C1 AC1 B 2 1555 1555 1.39
LINK O4 AC1 B 2 C1 GLC B 3 1555 1555 1.47
LINK O4 GLC B 3 C1 G6D B 4 1555 1555 1.40
LINK OD1 ASN A 100 CA CA A2502 1555 1555 2.36
LINK O ARG A 158 CA CA A2502 1555 1555 2.49
LINK OD1 ASP A 167 CA CA A2502 1555 1555 2.65
LINK OD2 ASP A 167 CA CA A2502 1555 1555 2.51
LINK O HIS A 201 CA CA A2502 1555 1555 2.62
LINK CA CA A2502 O HOH A2606 1555 1555 2.75
LINK CA CA A2502 O HOH A2607 1555 1555 2.99
LINK CA CA A2502 O HOH A2665 1555 1555 2.56
CISPEP 1 ASN A 53 PRO A 54 0 -0.09
CISPEP 2 VAL A 129 PRO A 130 0 -1.92
CRYST1 53.110 75.100 137.130 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018829 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013315 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007292 0.00000
HETATM 1 N PCA A 1 13.708 21.137 67.351 1.00 18.07 N
HETATM 2 CA PCA A 1 14.457 20.687 66.231 1.00 15.98 C
HETATM 3 CB PCA A 1 14.200 19.229 66.373 1.00 28.59 C
HETATM 4 CG PCA A 1 13.240 19.180 67.652 1.00 31.86 C
HETATM 5 CD PCA A 1 12.951 20.571 68.347 1.00 33.14 C
HETATM 6 OE PCA A 1 12.313 20.634 69.375 1.00 36.56 O
HETATM 7 C PCA A 1 13.720 21.321 65.067 1.00 14.23 C
HETATM 8 O PCA A 1 14.027 21.030 63.931 1.00 27.69 O